Item(by='sterlind', descendants=None, kids=None, score=None, time=1607326475, title=None, item_type='comment', url=None, parent=25328357, text='I had the timeline wrong, it was 2016-17 apparently (years have been a blur for me.)<p>There was (is?) a duopoly of manufacturers for estradiol valerate: Par and Perrigo. [0] Perrigo stopped manufacturing, only disclosing issues with &quot;shortages of an inactive component&quot; to the FDA and refusing further comment. Par said their supplier for the API pulled out, and had to rework their supply chain.<p>I eventually managed to track down a trans-run compounding pharmacy that had apparently stockpiled the stuff (so grateful to my community!) but it was a rough time and I&#x27;m glad my ex came through for me. Detransitioning is harrowing, I speak from experience.<p>0. <a href="http:&#x2F;&#x2F;www.ridgepoliticalreviews.com&#x2F;all-articles&#x2F;no-country-for-trans-women-persistent-shortages-of-injectable-estrogen-in-the-united-states" rel="nofollow">http:&#x2F;&#x2F;www.ridgepoliticalreviews.com&#x2F;all-articles&#x2F;no-country...</a>')